{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-069376","form_type":"8-K","ticker":"TRIN","cik":"0001786108","company_name":"Trinity Capital Inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.104365+00:00","generated_at":"2026-06-01T06:19:30.754571+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Trinity Capital exits Core Scientific equity position, realizes 17.7% IRR on $30M financing","bullets":["Trinity received 5,640,373 Core Scientific shares in satisfaction of $28.3M bankruptcy claim.","Shares sold at weighted avg price of $5.13/share, generating $29.0M in proceeds.","17.7% internal rate of return on original $30M equipment financing provided in 2021.","Core Scientific entered Chapter 11 in Dec 2022 and exited bankruptcy in Jan 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-069376","json":"https://secwatch.observer/filing/0000950170-24-069376.json","markdown":"https://secwatch.observer/filing/0000950170-24-069376.md","text":"https://secwatch.observer/filing/0000950170-24-069376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1786108/000095017024069376/0000950170-24-069376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1786108/000095017024069376/trin-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:19:30.754571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}